# iSTAR Medical and AbbVie enter strategic alliance for MINIject device

EQT Life Sciences announced that AbbVie and iSTAR Medical entered a strategic transaction to further develop and commercialize iSTAR Medical's MINIject device, a minimally invasive glaucoma surgical device. Deal terms include a $60 million upfront payment to iSTAR Medical.

- Type: Partnership
- Announced: 2022-09-20
- Value: $60.0M
- Status: announced
- Products: MINIject glaucoma surgical device
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [iSTAR Medical](https://endata.com/companies/64264.md)
- [AbbVie](https://endata.com/companies/29401.md) (partner)
- [EQT Life Sciences](https://endata.com/companies/65411.md) (investor)

## Sources

- [private-equitynews.com](https://www.private-equitynews.com/news/eqt-life-sciences-announces-strategic-alliance-of-its-portfolio-company-istar-medical-with-abbvie/), 2022-09-20: "Deal terms include a $60M upfront payment to iSTAR Medical."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.